Cargando…

Combined Administration of Preoperative Intravitreal and Intraoperative Subretinal Recombinant Tissue Plasminogen Activator in Acute Hemorrhagic Age-related Macular Degeneration

Purpose To evaluate the efficacy of combining pre-operative intravitreal administration of recombinant tissue plasminogen activator (rTPA) followed by 23G pars plana vitrectomy with the subretinal administration of rTPA in the management of acute submacular hemorrhage (SMH) secondary to neovascular...

Descripción completa

Detalles Bibliográficos
Autores principales:	Helaiwa, Khaled, Paez, Lina R, Szurman, Peter, Januschowski, Kai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2020
Materias:	Ophthalmology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065728/ https://www.ncbi.nlm.nih.gov/pubmed/32190528 http://dx.doi.org/10.7759/cureus.7229

Ejemplares similares

Subretinal Neovascular Membrane in Wet Age-Related Macular Degeneration Managed With Intravitreal Ranibizumab
por: Sharma, Tanishq S, et al.
Publicado: (2021)

Functional and structural outcome after vitrectomy combined with subretinal rtPA Injection with or without additional intravitreal Bevacizumab injection for submacular hemorrhages
por: Rickmann, Annekatrin, et al.
Publicado: (2021)

Assessment of Macular Function Following Internal Limiting Membrane Peeling With ILM Blue®
por: Rickmann, Annekatrin, et al.
Publicado: (2020)

Pain related to intravitreal injections for age-related macular degeneration: a qualitative study of the perspectives of patients and practitioners
por: Yiallouridou, Christina, et al.
Publicado: (2023)

Displacement of submacular hemorrhage secondary to age-related macular degeneration with subretinal injection of air and tissue plasminogen activator
por: Ogata, Maasa, et al.
Publicado: (2022)

Intravitreal Bevacizumab for Choroidal Neovascular Membrane in Macular Telangiectasia Type 2
por: Gonzalez Martinez, Orlando G, et al.
Publicado: (2023)

Two-step versus 1-step subretinal injection to compare subretinal drug delivery: a randomised study protocol
por: Simunovic, Matthew P, et al.
Publicado: (2021)

Submacular Hemorrhage Following Aflibercept Intravitreal Injection: A Report of Two Cases
por: Khoo, Chloe, et al.
Publicado: (2022)

Full-Thickness Macular Hole After Intravitreal Conbercept Injection in Branch Retinal Vein Occlusion
por: Xie, Pinxue, et al.
Publicado: (2023)

Tolerating subretinal fluid in the treatment of neovascular age-related macular degeneration with intravitreal aflibercept
por: Yildiz, Dilan, et al.
Publicado: (2021)

Age-Related Macular Degeneration: Epidemiology, Pathophysiology, Diagnosis, and Treatment
por: Vyawahare, Hrishikesh, et al.
Publicado: (2022)

Reduction in choroidal thickness of macular area in polypoidal choroidal vasculopathy patients after intravitreal ranibizumab therapy
por: Nishide, Tadayuki, et al.
Publicado: (2013)

Subretinal Coapplication of Tissue Plasminogen Activator and Bevacizumab with Concurrent Pneumatic Displacement for Submacular Hemorrhages Secondary to Neovascular Age-Related Macular Degeneration
por: Avcı, Remzi, et al.
Publicado: (2021)

Subretinal tissue plasminogen-assisted vitrectomy for posttraumatic full-thickness macular hole with submacular hemorrhage
por: Kumar, Pradeep, et al.
Publicado: (2018)

Subretinal Injection of Recombinant Tissue Plasminogen Activator and Gas Tamponade to Displace Acute Submacular Haemorrhages Secondary to Age-Related Macular Degeneration
por: Iannetta, Danilo, et al.
Publicado: (2021)

Antiplatelet and anticoagulant therapy in patients with submacular hemorrhage caused by neovascular age-related macular degeneration
por: Weber, Constance, et al.
Publicado: (2022)

An Analysis of the Usage of Retinal Imaging Technology in the Detection of Age-Related Macular Degeneration
por: Riazi Esfahani, Parsa, et al.
Publicado: (2023)

Ranibizumab therapy for predominantly hemorrhagic neovascular age-related macular degeneration
por: Dikmetas, Ozlem, et al.
Publicado: (2022)

Subretinal recombinant tissue plasminogen activator and pneumatic displacement for the management of subretinal hemorrhage occurring after anti-VEGF injections for wet AMD
por: Tognetto, Daniele, et al.
Publicado: (2011)

An Uncommon Aflibercept Side Effect: Full Thickness Macular Hole Formation After Intravitreal Injections in Patients With Pre-existing Vitreomacular Traction
por: Karamitsos, Athanasios, et al.
Publicado: (2021)

Subretinal alteplase injections in massive subretinal hemorrhage due to age-related macular degeneration: A case report series
por: Ochinciuc, Radu, et al.
Publicado: (2020)

Dietary intervention in patients with age-related macular degeneration: protocol for a randomised controlled trial
por: Tang, Diana, et al.
Publicado: (2019)

A Study of Correlates of Age-Related Macular Degeneration in Patients Attending a Tertiary Hospital
por: Mehta, Kervi, et al.
Publicado: (2022)

Age-Related Macular Degeneration: An Exponentially Emerging Imminent Threat of Visual Impairment and Irreversible Blindness
por: Chaudhuri, Madhurima, et al.
Publicado: (2023)

Healthcare experiences of patients with age-related macular degeneration: have things improved? Cross-sectional survey responses of Macular Society members in 2013 compared with 1999
por: Boxell, Emily M, et al.
Publicado: (2017)

Co-existence of Age-Related Macular Degeneration and Diabetic Retinopathy in a Tertiary Referral Center in Greece
por: Bourouki, Evgenia, et al.
Publicado: (2022)

Patient perspectives and barriers in the treatment of neovascular age-related macular degeneration in Denmark: a qualitative study
por: Thinggaard, Benjamin Sommer, et al.
Publicado: (2023)

Transconjunctival sutureless vitrectomy with tissue plasminogen activator, gas and intravitreal bevacizumab in the management of predominantly hemorrhagic age-related macular degeneration
por: Arias, Luis, et al.
Publicado: (2010)

Intravitreal Injection-Induced Migraine Headaches
por: Lerebours, Valerie C, et al.
Publicado: (2016)

Anti-VEGF therapies in the treatment of choroidal neovascularisation secondary to non-age-related macular degeneration: a systematic review
por: Stuart, Arabella, et al.
Publicado: (2015)

Patient experience of treatment decision making for wet age-related macular degeneration disease: a qualitative study in China
por: Bian, Wei, et al.
Publicado: (2019)

Clinical Wide-Field Retinal Image Deep Learning Classification of Exudative and Non-Exudative Age-Related Macular Degeneration
por: Tak, Nathaniel, et al.
Publicado: (2021)

Cross-sectional study evaluating burden and depressive symptoms in family carers of persons with age-related macular degeneration in Australia
por: Jin, Ivan, et al.
Publicado: (2021)

Eligibility for faricimab in a real-world neovascular age-related macular degeneration population: a cross-sectional study
por: Jern, Iréne, et al.
Publicado: (2022)

Faricimab Effectively Resolves Intraretinal Fluid and Preserves Vision in Refractory, Recalcitrant, and Nonresponsive Neovascular Age-Related Macular Degeneration
por: Cheng, Anny M, et al.
Publicado: (2023)

Risk factors for breakthrough vitreous hemorrhage after intravitreal tissue plasminogen activator and gas injection for submacular hemorrhage associated with age related macular degeneration
por: Lim, Jun Hyun, et al.
Publicado: (2020)

Intravitreal Anti-vascular Endothelial Growth Factor (Anti-VEGF) Therapy for Valsalva Related Sub-internal Limiting Membrane (Sub-ILM) Macular Haemorrhage: A Case Report
por: Nur-Najwa, Suhaifi, et al.
Publicado: (2023)

Submacular hemorrhage secondary to age-related macular degeneration managed with vitrectomy, subretinal injection of tissue plasminogen activator, hemorrhage displacement with liquid perfluorocarbon, gas tamponade, and face-down positioning()
por: Ozkaya, Abdullah, et al.
Publicado: (2018)

Multimodal imaging of macular subretinal deposits following intravitreal ocriplasmin injection
por: Chow, Nicholas, et al.
Publicado: (2018)

How does age-related macular degeneration affect real-world visual ability and quality of life? A systematic review
por: Taylor, Deanna J, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_sbj48f3e44ni5fpspu4736k7ja